FORTRESS BIOTECH INC.

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

14 ноя 2024 16:10:31 Источник Nasdaq GlobeNewswire

Fortress Biotech to Participate in October 2024 Investor Conferences

26 сен 2024 08:30:50 Источник Nasdaq GlobeNewswire

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

20 сен 2024 08:30:35 Источник Nasdaq GlobeNewswire

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

04 сен 2024 08:30:11 Источник Nasdaq GlobeNewswire

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

13 авг 2024 16:05:46 Источник Nasdaq GlobeNewswire

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

25 июл 2024 08:30:53 Источник Nasdaq GlobeNewswire

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

05 июл 2024 16:05:00 Источник Nasdaq GlobeNewswire

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

16 май 2024 08:00:38 Источник Nasdaq GlobeNewswire

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

15 май 2024 16:15:29 Источник Nasdaq GlobeNewswire

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

14 май 2024 08:30:00 Источник Nasdaq GlobeNewswire

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

28 мар 2024 16:05:13 Источник Nasdaq GlobeNewswire